156 related articles for article (PubMed ID: 37687081)
21. Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.
Zhu J; Xu M; Gao M; Zhang Z; Xu Y; Xia T; Liu S
ACS Nano; 2017 Mar; 11(3):2637-2651. PubMed ID: 28208020
[TBL] [Abstract][Full Text] [Related]
22. Synergistic anti-cancer action of salicylic acid and cisplatin on HeLa cells elucidated by network pharmacology and in vitro analysis.
Sidhu H; Capalash N
Life Sci; 2021 Oct; 282():119802. PubMed ID: 34237314
[TBL] [Abstract][Full Text] [Related]
23. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
[TBL] [Abstract][Full Text] [Related]
24. Metformin enhances inhibitive effects of carboplatin on HeLa cell proliferation and increases sensitivity to carboplatin by activating mitochondrial associated apoptosis signaling pathway.
Tang ZY; Sheng MJ; Qi YX; Wang LY; He DY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8104-8112. PubMed ID: 30556847
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic and Apoptogenic Effects of Cyanidin-3-Glucoside on the Glioblastoma Cell Line.
Hosseini MM; Karimi A; Behroozaghdam M; Javidi MA; Ghiasvand S; Bereimipour A; Aryan H; Nassiri F; Jangholi E
World Neurosurg; 2017 Dec; 108():94-100. PubMed ID: 28867321
[TBL] [Abstract][Full Text] [Related]
26. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
Du YH; Ho PC
Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
[TBL] [Abstract][Full Text] [Related]
27. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
[TBL] [Abstract][Full Text] [Related]
28. Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism.
Li C; Ye H
Eur J Gynaecol Oncol; 2013; 34(2):142-7. PubMed ID: 23781585
[TBL] [Abstract][Full Text] [Related]
29. Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage.
Wu X; Zhong Y; Chen Q; Zhang X; Zhang H
Hereditas; 2020 Oct; 157(1):41. PubMed ID: 33054858
[TBL] [Abstract][Full Text] [Related]
30. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
31. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
Padilla LA; Leung BS; Carson LF
Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121
[TBL] [Abstract][Full Text] [Related]
32. Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells.
Qi J; Chen Y; Xue T; Lin Y; Huang S; Cao S; Wang X; Su Y; Lin Z
Nanotechnology; 2020 Jan; 31(6):065102. PubMed ID: 31645027
[TBL] [Abstract][Full Text] [Related]
33. The chemosensitizing effect of aqueous extract of sweet fennel on cisplatin treated HeLa cells.
Ramadan WS; Sait KH; Anfinan NM; Sait H
Clin Exp Obstet Gynecol; 2016; 43(3):358-64. PubMed ID: 27328491
[TBL] [Abstract][Full Text] [Related]
34. [Role of high mobility group box-1 in chemo-sensitivity in cervical cancer].
Zhu F; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):14-21. PubMed ID: 30154286
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance.
Leisching G; Loos B; Botha M; Engelbrecht AM
J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854
[TBL] [Abstract][Full Text] [Related]
36. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
37. Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
Yamaguchi K; Matsumoto Y; Suzuki R; Nishida H; Omata D; Inaba H; Kukita A; Tanikawa M; Sone K; Oda K; Osuga Y; Maruyama K; Fujii T
Cancer Sci; 2021 Jun; 112(6):2493-2503. PubMed ID: 33793049
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
[TBL] [Abstract][Full Text] [Related]
39. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
40. Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.
Fathy M; Fawzy MA; Hintzsche H; Nikaido T; Dandekar T; Othman EM
Molecules; 2019 Nov; 24(21):. PubMed ID: 31684176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
